CVI Investments, Inc. 13D and 13G filings for Silexion Therapeutics Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-12 12:12 pm Purchase | 2025-03-31 | 13G | SILEXION THERAPEUTICS CORP SLXN | CVI Investments, Inc. | 30,435 4.900% | 7,835 (+34.67%) | Filing |
| 2025-01-23 12:19 pm Purchase | 2025-01-15 | 13G | SILEXION THERAPEUTICS CORP SLXN | CVI Investments, Inc. | 22,600 8.500% | 22,600 (New Position) | Filing |